Core Viewpoint - Eric M. Green plans to retire as President, CEO, and Chair of West Pharmaceutical Services, Inc. once a successor is appointed, aiming for a smooth transition in the second half of 2026 [1][1][1] Company Leadership Transition - The Board of Directors is engaging an executive recruiting firm to assist in finding a successor for Eric M. Green [1][1] - Green has served as CEO since April 2015 and became Chair of the Board in May 2022 [1][1] Company Performance and Achievements - Under Green's leadership, the company has more than doubled its sales and achieved a total shareholder return of approximately 350% over his eleven-year tenure [1][1][1] - The company has driven innovations to meet patient needs and supported vaccine delivery during the COVID pandemic, significantly growing its global impact [1][1] Company Overview - West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services, supporting drug developers with safe and effective containment and delivery of medicines [1][1] - In fiscal year 2025, the company generated $3.07 billion in net sales and operates over 50 sites, including 25 manufacturing facilities worldwide [1][1]